Navigation Links
BD Receives FDA Approval for New Automated Cervical Cancer Screening System
Date:3/7/2016

FRANKLIN LAKES, N.J., March 7, 2016 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has received U.S. Food and Drug Administration (FDA) approval for its  BD Totalys™ MultiProcessor and BD Totalys™ SlidePrep instruments.

Together with the BD FocalPoint™ SlideProfiler, these innovations comprise the full BD Totalys System, which further automates slide preparation, imaging and review for use in cervical cancer screening, as well as providing ancillary testing aliquot capability. Increasing automation in the laboratory helps to reduce the potential for human error and increases lab workflow efficiency. The BD™ DataLink middleware connects the BD Totalys instruments to a Laboratory Information System, improving laboratory efficiency while providing continuous sample tracking to ensure patients get the right results.

The BD Totalys System combined with the BD SurePath™ liquid-based Pap test offers an improved automated process for cervical cancer screening laboratories versus current methods.

"We are very pleased to introduce the BD Totalys System in the United States," said Doug White, vice president and general manager, Women's Health & Molecular Diagnostics. "The BD Totalys System provides clinical laboratories with a highly customizable, automated liquid-based cytology solution to help improve laboratory efficiency, enhance sample tracking and maintain high quality diagnostic results."

The BD Totalys System provides a balance of automation and flexibility to help meet the needs of medium and high throughput cervical cancer screening labs by increasing workflow efficiency, reducing technician hands-on time and repetitive motion and improving usability, user safety, overall process quality and functionality.

About BD
BD is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and health care worker safety and the technologies that enable medical research and clinical laboratories. The company provides innovative solutions that help advance cellular studies and genomics, enhance the diagnosis of infectious disease and cancer, improve medication management, promote infection prevention, equip surgical and interventional procedures, optimize respiratory care and support the management of diabetes. The company partners with organizations around the world to address some of the most challenging global health issues. BD has more than 45,000 associates across 50 countries who work in close collaboration with customers and partners to help enhance outcomes, lower health care delivery costs, increase efficiencies, improve health care safety and expand access to health. For more information on BD, please visit www.bd.com.

Contact:

Matthew Coppola
BD Public Relations
201.847.7330
Matthew_R_Coppola@bd.com

Monique N. Dolecki
BD Investor Relations
201.847.5378
Monique_Dolecki@bd.com


'/>"/>
SOURCE BD (Becton, Dickinson and Company)
Copyright©2016 PR Newswire.
All rights reserved


Related medicine technology :

1. Corvia Medical Receives IDE Approval For REDUCE LAP-HF I Clinical Study & Announces Agreement With Strategic Partner For Exclusive Option To Purchase Company
2. Edwards SAPIEN XT Valve Receives FDA Approval For Pulmonic Procedures
3. Lilly Receives Positive CHMP Opinion for Ixekizumab for the Treatment of Moderate-to-Severe Plaque Psoriasis
4. AbbVie Receives EMA Orphan Drug Designation for Investigational Compound Venetoclax for the Treatment of Acute Myeloid Leukemia (AML)
5. MediHerb/Integria Healthcare Receives ABCs Varro E. Tyler Award for Phytomedicinal Research
6. Renova Therapeutics receives additional NIH grant to continue paracrine gene therapy research for congestive heart failure
7. Boston Scientific Receives U.S. FDA Approval For Quadripolar Leads And Initiates Global Trial To Expand MRI Labeling To The U.S. And Asia
8. Luminex Corporation Receives Medical Device License for ARIES System and ARIES HSV 1&2 Assay in Canada
9. Bracco Diagnostics Inc. Receives Second U.S. FDA Approval for Barium-Based Products, The First in Computed Tomography
10. BiondVax Receives Additional Grant Approval
11. ivWatch, LLC Receives 2016 Virginia Governors Outstanding STEM Award for Science Innovation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/13/2018)... NASHVILLE, Tenn. (PRWEB) , ... November 13, 2018 ... ... Group, has joined the Center for Medical Interoperability Board. , “We are ... care of people can seamlessly exchange information and be easily swapped out as ...
(Date:11/13/2018)... ... November 13, 2018 , ... ... new features to its flagship solution, MCenter™, that support a wider variety of ... companies and AI service providers. , “By partnering with our customers and ...
(Date:11/13/2018)... ... November 13, 2018 , ... Intrepy Healthcare ... SEO, social media, digital advertising and physician liaison services is announcing the launch ... looking to successfully grow their practice can visit the new Intrepy Healthcare ...
Breaking Medicine Technology:
(Date:11/15/2018)... ... , ... Through its Microbiome Grant Initiative , uBiome, the leader in ... analysis to a team of UCLA Department of Urology researchers led by Dr. William ... microbiome of a low-fat diet supplemented with fish oil in patients diagnosed with localized ...
(Date:11/15/2018)... ... November 15, 2018 , ... ... the release of “Loneliness in Our Human Code”, ( https://www.goinvo.com/vision/loneliness-in-our-human-code/ ) the latest ... of Health. This visual essay explores how social determinants of health, with a ...
(Date:11/14/2018)... ... November 14, 2018 , ... Racial ... areas and in regions experiencing shortages. The Association of American Medical Colleges ... populations , Researchers from the American Board of Family Medicine (ABFM) aggregated racial ...
(Date:11/14/2018)... ... 2018 , ... PAINWeekEnd on Saturday, December 1, at the Hyatt Regency Baltimore ... providing busy clinicians and allied healthcare practitioners with 6.0 hours of relevant, practical instruction ... Drug Abuse, Maryland is among the top five states in the nation in the ...
(Date:11/14/2018)... ... ... The Austin-area sports medicine team at Medicine in Motion is reminding ... plan paperwork to review coverage and assess how many unused insurance benefits remains. Whether ... by taking a few minutes for an insurance plan evaluation. , “With the ...
Breaking Medicine News(10 mins):